
    
      The study(n = 12) will use a one-dose design to measure bioavailability and pharmacokinetic
      properties of an aqueous extract of H. procumbens containing 100mg harpagoside. Plasma levels
      of harpagoside, harpagide, verbascoside, and 8-p-coumarylharpagide will be measured for 24
      hours with blood collections taken at timed intervals.
    
  